JP2024517345A5 - - Google Patents
Info
- Publication number
- JP2024517345A5 JP2024517345A5 JP2023570240A JP2023570240A JP2024517345A5 JP 2024517345 A5 JP2024517345 A5 JP 2024517345A5 JP 2023570240 A JP2023570240 A JP 2023570240A JP 2023570240 A JP2023570240 A JP 2023570240A JP 2024517345 A5 JP2024517345 A5 JP 2024517345A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- sequence
- cov
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21173941.2A EP4088738A1 (en) | 2021-05-14 | 2021-05-14 | Novel protein and nucleic acid sequences for covid-19 vaccines |
| EP21173941.2 | 2021-05-14 | ||
| PCT/EP2022/063214 WO2022238585A1 (en) | 2021-05-14 | 2022-05-16 | Novel protein and nucleic acid sequences for covid-19 vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517345A JP2024517345A (ja) | 2024-04-19 |
| JP2024517345A5 true JP2024517345A5 (enExample) | 2025-04-21 |
Family
ID=75936784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023570240A Pending JP2024517345A (ja) | 2021-05-14 | 2022-05-16 | Ｃｏｖｉｄ－１９ワクチンのための新規のタンパク質および核酸配列 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250282831A1 (enExample) |
| EP (2) | EP4088738A1 (enExample) |
| JP (1) | JP2024517345A (enExample) |
| CN (1) | CN117915945A (enExample) |
| AU (1) | AU2022272659A1 (enExample) |
| BR (1) | BR112023023794A2 (enExample) |
| CA (1) | CA3219586A1 (enExample) |
| IL (1) | IL308407A (enExample) |
| WO (1) | WO2022238585A1 (enExample) |
| ZA (1) | ZA202311432B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024245344A1 (zh) * | 2023-05-30 | 2024-12-05 | 石药集团巨石生物制药有限公司 | 预防新型冠状病毒奥密克戎突变株的mRNA疫苗 |
-
2021
- 2021-05-14 EP EP21173941.2A patent/EP4088738A1/en not_active Withdrawn
-
2022
- 2022-05-16 EP EP22729202.6A patent/EP4337250A1/en active Pending
- 2022-05-16 BR BR112023023794A patent/BR112023023794A2/pt unknown
- 2022-05-16 WO PCT/EP2022/063214 patent/WO2022238585A1/en not_active Ceased
- 2022-05-16 CA CA3219586A patent/CA3219586A1/en active Pending
- 2022-05-16 IL IL308407A patent/IL308407A/en unknown
- 2022-05-16 AU AU2022272659A patent/AU2022272659A1/en active Pending
- 2022-05-16 JP JP2023570240A patent/JP2024517345A/ja active Pending
- 2022-05-16 US US18/290,356 patent/US20250282831A1/en active Pending
- 2022-05-16 CN CN202280048066.0A patent/CN117915945A/zh active Pending
-
2023
- 2023-12-12 ZA ZA2023/11432A patent/ZA202311432B/en unknown